Research presented at ATS 2026 reveals that positional therapy conditions patients to avoid back-sleeping, maintaining obstructive sleep apnea control for up to a year after device withdrawal.

New research challenges the 90-day CPAP compliance policy.

What can sleep physicians do when obstructive sleep apnea patients can't afford every recommended therapy?

The acquisition adds the FDA-cleared, non-pharmacologic Nidra TOMAC therapy to Resmed’s portfolio, expanding its reach into the treatment of restless legs syndrome.

The new rechargeable home sleep test integrates more sensors than the original, including thermistors, an optical module, and a mic.

New research identifies a "strong response endotype" of patients who experience nearly double the sleep apnea improvement from tirzepatide.

The acquisition of PONM gives Nexalin ownership of the AI-integrated software supporting its HALO Clarity program, preparing for a 160-participant trial for moderate-to-severe insomnia.

The brain has neuronal systems that respond to skin temperature. In narcolepsy, these systems act as a switch, determining whether the brain enters REM sleep or triggers muscle paralysis while the person is awake.

'The medical device industry has long assumed that mass production and true personalization are incompatible. FormFit proves they are not.'

The collaboration aims to close the sleep apnea awareness gap by directing Oura Ring users with nighttime breathing disturbances to Resmed’s educational and clinical resources.